What is the Impact Factor of Hiv Research & Clinical Practice?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Hiv Research & Clinical Practice is 2.10, ranking in quartile Q3 of Web of Science (SCIE).

Is Hiv Research & Clinical Practice indexed in Web of Science or Scopus?

Yes, Hiv Research & Clinical Practice is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.580 (Q2) and an H-index of 57.

Who publishes Hiv Research & Clinical Practice and what is the Article Processing Charge (APC)?

Hiv Research & Clinical Practice is published by TAYLOR & FRANCIS LTD. The estimated Article Processing Charge (APC) is approximately $3,035 USD, subject to institutional waivers and corresponding author affiliations.

WoS SCIE Q3Scopus Q2SCImago #10,214Gold OA

Hiv Research & Clinical Practice

Identifier (ISSN):2578-7489(Print)/2578-7470(Online)

•

Publisher:TAYLOR & FRANCIS LTD

Official Website Submission Portal Compare

Clarivate IF (2026)

2.1↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2022–2026)

Clarivate IF trend for Hiv Research & Clinical Practice

WoS Q3

Annual Impact Factor Metric

Current (2026):2.1

Scopus SJR & RankScopus Q2

0.58

#10,214

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

57 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate5.9%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

21articles/year

100% Gold OA•83.33% Original Research

Aims & Scope

Hiv Research & Clinical Practice (ISSN: 2578-7489) is a peer-reviewed international scholarly journal in the field of Multiple, published by TAYLOR & FRANCIS LTD in England. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.580 (Q2), an H-index of 57.

Topics Covered (Recognized by AI)

MedicineBiology95.5%Immunology85.2%Internal medicine85.2%Virology81.8%Family medicine80.7%Human immunodeficiency virus (HIV)79.5%Genetics68.2%Pathology64.8%Virus55.7%Viral load53.4%Surgery47.7%Antiretroviral therapy47.7%Endocrinology37.5%Chemistry34.1%Pharmacology33%Psychology33%Biochemistry31.8%Mathematics29.5%Statistics29.5%Psychiatry23.9%Dolutegravir21.6%Lamivudine20.5%Hepatitis B virus20.5%Chronic hepatitis20.5%

Primary Research Areas

Multiple

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

INFECTIOUS DISEASES

Rank95/141

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank240/356

IndexSCIE

JCISCIE2026

INFECTIOUS DISEASES

Rank92/141

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank218/356

IndexSCIE

Category	Index	Rank	Quartile
INFECTIOUS DISEASES	JCRSCIE	95/141	Q3
PHARMACOLOGY & PHARMACY	JCRSCIE	240/356	Q3
INFECTIOUS DISEASES	JCISCIE	92/141	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	218/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

8 year

2026Latest

IF2.1

Articles / Year18

Total Citations3

2025

IF1.8

Articles / Year29

Total Citations37

2024

IF1.7

Articles / Year41

Total Citations123

2023

IF1.6

Articles / Year15

Total Citations97

2022

IF1.676

Articles / Year13

Total Citations88

Year	Impact Factor	Articles / Year	Total Citations
2026	2.1	18	3
2025	1.8	29	37
2024	1.7	41	123
2023	1.6	15	97
2022	1.676	13	88
2021	—	18	229
2020	—	20	199
2019	—	16	181

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,214Scopus Q2SCImago Profile

Scopus Coverage:2019-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.58

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.13

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,035 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations135

3-Year Documents65

Citable Documents60

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate57.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ2

Pharmacology (medical)Q3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区INFECTIOUS DISEASES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 21 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,035 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.